Literature DB >> 30218421

Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis.

Serena Pelusi1, Federica Iuculano2, Rosa Lombardi2, Paolo Francione2, Umberto Gianelli3, Anna Ludovica Fracanzani2, Silvia Fargion2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30218421     DOI: 10.1007/s11739-018-1947-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor.

Authors:  Joaquín Martinez-Lopez; Ana Jimenez; Jorge Sanchez-Calero; Dolores Monteagudo; María Urbanowicz; Irene Cañamares-Orbis; Susana Cortijo-Cascajares; Rosa Ayala
Journal:  Ann Hematol       Date:  2015-03-21       Impact factor: 3.673

2.  Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.

Authors:  Andrea Piccin; Michael Steurer; Manfred Mitterer; Elisabeth Maria Blöchl; Luigi Marcheselli; Irene Pusceddu; Alessandra Marabese; Irene Bertozzi; Daisy Corvetta; Maria Luigia Randi; Elena Elli; Enrico Maria Pogliani; Dino Veneri; Omar Perbellini; Mauro Krampera; Enrica Pacquola; Michele Gottardi; Mario Tiribelli; Anna Guella; Barbara Innella; Paolo Vivaldi; Ercole De Biasi; Rosaria Sancetta; Roberta Rocconi; Renato Bassan; Filippo Gherlinzoni; Giovanni Pizzolo; Günther Gastl; Sergio Cortelazzo
Journal:  Intern Emerg Med       Date:  2015-01-14       Impact factor: 3.397

3.  Haemochromatosis in patients with beta-thalassaemia trait.

Authors:  A Piperno; R Mariani; C Arosio; A Vergani; S Bosio; S Fargion; M Sampietro; D Girelli; M Fraquelli; D Conte; G Fiorelli; C Camaschella
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

4.  Epidemiological data in polycythaemia vera: a study of 842 cases.

Authors:  Y Najean; J D Rain; C Billotey
Journal:  Hematol Cell Ther       Date:  1998-08

5.  HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.

Authors:  Hajnalka Andrikovics; Nora Meggyesi; Aniko Szilvasi; Julia Tamaska; Gabriella Halm; Sandor Lueff; Sarolta Nahajevszky; Miklos Egyed; Judit Varkonyi; Gabor Mikala; Andrea Sipos; Laszlo Kalasz; Tamas Masszi; Attila Tordai
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

6.  HFE C282Y and H63D in adults with malignancies in a community medical oncology practice.

Authors:  James C Barton; Luigi F Bertoli; Ronald T Acton
Journal:  BMC Cancer       Date:  2004-02-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.